Zhigang Bai

Zhigang Bai

Auto-generated profile, based on publicly available information

Zhigang Bai

Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2011 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
JSJianning Song
Jianning Song
ZBZhigang Bai
Zhigang Bai
WHWei Han
Wei Han
JZJun Zhang
Jun Zhang
HMHua Meng
Hua Meng
ZZZhongtao Zhang
Zhongtao Zhang

4 September 2020 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
GWGuangchuan Wang
Guangchuan Wang
RCRyan D. Chow
Ryan D. Chow
LZLvyun Zhu
Lvyun Zhu
ZBZhigang Bai
Zhigang Bai
LYLupeng Ye
Lupeng Ye
SCSidi Chen
Sidi Chen
Immune checkpoint blockade (ICB) has shown remarkable clinical efficacy in several cancer types. However, only a fraction of patients will respond to ICB. Here, we performed pooled mutagenic screening with CRISPR-mediated genetically engineered mouse models (CRISPR-GEMM) in ICB settings, and identified KMT2D as a major modulator of ICB response across multiple cancer types. KMT2D encodes a histone H3K4 methyltransferase and is among the most frequently mutated genes in patients with cancer. Kmt2d loss led to increased DNA damage and mutation burden, chromatin remodeling, intron retention, and activation of transposable elements. In addition, Kmt2d-mutant cells exhibited increased protein turnover and IFNγ-stimulated antigen presentation. In turn, Kmt2d-mutant tumors in both mouse and human were characterized by increased immune infiltration. These data demonstrate that Kmt2d deficiency sensitizes tumors to ICB by augmenting tumor immunogenicity, and also highlight the power of CRISPR-GEMMs for interrogating complex molecular landscapes in immunotherapeutic contexts that preserve the native tumor microenvironment.Significance: ICB is ineffective in the majority of patients. Through direct in vivo CRISPR mutagenesis screening in GEMMs of cancer, we find Kmt2d deficiency sensitizes tumors to ICB. Considering the prevalence of KMT2D mutations, this finding potentially has broad implications for patient stratification and clinical decision-making.This article is highlighted in the In This Issue feature, p. 1775

14 October 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
GWGuangchuan Wang
Guangchuan Wang
RCRyan D. Chow
Ryan D. Chow
ZBZhigang Bai
Zhigang Bai
LZLvyun Zhu
Lvyun Zhu
YEYoussef Errami
Youssef Errami
SCSidi Chen
Sidi Chen

23 September 2015 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
JZJ G Zhu
J G Zhu
WHW Han
W Han
WGW Guo
W Guo
WSW Su
W Su
ZBZ G Bai
Z G Bai
ZZZ T Zhang
Z T Zhang
Background: The best approach for cholecystocholedocholithiasis remains a matter of debate. The aim of this study was to evaluate the technical aspects, learning curve and outcome of laparoscopic transcystic common bile duct exploration (LTCBDE). Methods: Patients who underwent laparoscopic cholecystectomy with LTCBDE between January 2007 and December 2012 were identified from an institutional database. Data on preoperative investigations, intraoperative and postoperative findings were retrieved retrospectively from the patients' hospital notes. Results: There were 399 women (56·4 per cent) and 309 men (43·6 per cent), with a median age of 58 (range 18–87) years. Microincision (incision of the cystic duct at the confluence with the common bile duct (CBD) with extension of only 3–5 mm at the lateral margin of the CBD) and lithotripsy were used in the transcystic exploration in 119 patients, and increased the success rate of LTCBDE from 74·2 to 91·0 per cent. The median duration of operation was 85 (i.q.r. 65–120) min and the median postoperative hospital stay was 2 (1–3) days. Retained common bile duct stones were observed in 13 patients, and postoperative complications developed in 27 patients. The cumulative sum duration of operation learning curve comprised two phases; phase 1 included the first 250 patients and phase 2 the remaining 458 patients. Duration of operation and postoperative hospital stay decreased with increasing volume per surgeon. Recurrence of common bile duct stones was diagnosed in 26 patients during a median follow-up of 4 years. Conclusion: LTCBDE with or without microincision and/or lithotripsy is a safe and effective approach.

29 March 2016 in IUBMB Life
Verified
Journal Article
Open access
PDF file
WDWei Deng
Wei Deng
JWJin Wang
Jin Wang
JZJun Zhang
Jun Zhang
JCJun Cai
Jun Cai
ZBZhigang Bai
Zhigang Bai
ZZZhongtao Zhang
Zhongtao Zhang
Ten‐eleven translocation (TET) family enzymes convert 5‐methylcytosine to 5‐hydroxymethylcytosine in DNA. However, the role of TET enzymes in human gastric cancer remains unknown. Here, we show that TET2 mRNA and protein levels are downregulated in human gastric cancer tissues when compared with normal gastric mucosa. Low expression of TET2 predicts poor overall and disease‐free survival. Furthermore, we demonstrate that TET2 inhibits the proliferation and colony formation of human gastric cancer cells by using loss‐of‐function and gain‐of‐function strategies. Overexpression of TET2 induces apoptosis in human gastric cancer cells. The mechanism study shows that TET2 binds to the promoter region of the oncogenic long noncoding RNA (lncRNA‐ANRIL) and regulates the expression of ANRIL and its downstream genes (INK4a, INK4b, and ARF). Finally, we demonstrate that ANRIL knockdown blocks the effects of TET2 on gastric cancer cell proliferation and colony formation. © 2016 IUBMB Life 68(5):355–364, 2016

10 June 2019 in PeerJ
Verified
Journal Article
Open access
PDF file
BXBodong Xu
Bodong Xu
ZBZhigang Bai
Zhigang Bai
JYJie Yin
Jie Yin
ZZZhongtao Zhang
Zhongtao Zhang
Background: The plasminogen activation system plays a pivotal role in regulating tumorigenesis. In this work, we aim to identify key regulators of plasminogen activation associated with tumorigenesis and explore potential mechanisms in gastric cancer (GC).Methods: Gene profiling datasets were extracted from the Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) were screened for and obtained by the GEO2R tool. The Database for Annotation, Visualization and Integrated Discovery was used for GO and KEGG enrichment analysis. Gene set enrichment analysis (GSEA) was performed to verify molecular signatures and pathways among The Cancer Genome Atlas or GEO datasets. Correlations between SERPINE1 and markers of epithelial-to-mesenchymal transition (EMT) were analyzed using the GEPIA database and quantitative real-time PCR (qRT-PCR). Interactive networks of selected genes were built by STRING and Cytoscape software. Finally, selected genes were verified with the Kaplan–Meier (KM) plotter database.Results: A total of 104 overlapped upregulated and 61 downregulated DEGs were obtained. Multiple GO and KEGG terms associated with the extracellular matrix were enriched among the DEGs. SERPINE1 was identified as the only regulator of angiogenesis and the plasminogen activator system among the DEGs. A high level of SERPINE1 was associated with a poor prognosis in GC. GSEA analysis showed a strong correlation between SERPINE1 and EMT, which was also confirmed with the GEPIA database and qRT-PCR validation. FN1, TIMP1, MMP2, and SPARC were correlated with SERPINE1.The KM plotter database showed that an overexpression of these genes correlated with a shorter survival time in GC patients.Conclusions: In conclusion, SERPINE1 is a potent biomarker associated with EMT and a poor prognosis in GC. Furthermore, FN1, TIMP1, MMP2, and SPARC are correlated with SERPINE1 and may serve as therapeutic targets in reversing EMT in GC.